Varian Medical Systems (VAR) Misses Q4 EPS by 4c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Varian Reports Results for Fourth Quarter and Full Fiscal Year 2018
October 23, 2018 4:06 PM EDTPALO ALTO, Calif., Oct. 23, 2018 /PRNewswire/ --
Fourth Quarter 2018 Summary       Oncology gross orders grew 13% in dollars, or 14% in constant currency       84 Halcyon orders in the quarter       Total company revenues of $802 million grew 11%, or 12% in constant currency       GAAP operating earnings grew 29% at 16.8% of revenues; Non-GAAP operating earnings grew 14% at 17.8% of revenues       GAAP net earnings per diluted share from continuing operations of $1.26; Non-GAAP net earnings per diluted share from continuing operations of $1.16
Fiscal Year 2018 Summary       Oncology gross orders grew 9%, or 8% in constant currency       Added 224 linear accelerators to the installed base which is now greater than 8,000 units       Total company revenues of $2.9... More
